CASP9 and lung cancer: Bufalin decreases NCI-H460 cell activity in lung cancer and blocks tumor cells in the G0/G1 and G2/M phases, promoting apoptosis by increasing the production of oxygen-free radicals, caspase-1, and caspase-9 [25, 26].